


Autophagy contributes to resistance to ruxolitinib in myeloproliferative neoplasms
Autophagy contributes to resistance to ruxolitinib in myeloproliferative neoplasms Autophagy, Protein Phosphatase 2A, Myeloproliferative neoplasms. Carine Joffre and Véronique De-Mas team METAML : Metabolism and Therapeutic Resistance In Acute Myeloid Leukemia The...
CD36 drives metastasis and relapse in acute myeloid leukemia
CD36 drives metastasis and relapse in acute myeloid leukemia Acute myeloid leukemia, metastasis, CD36, relapse. Thomas Farge , Jean Nakhle audrey Carrière-Pazat Team METAML : Metabolism and Therapeutic Resistance In Acute Myeloid Leukemiaet METABOLINK of Restore...
A new target to fight certain aggressive leukaemias
A new target to fight certain aggressive leukaemias Acute Myeloid Leukemia, FLT3, C/AAT-enhancer binding protein α, Jean-Emmanuel Sarry Team METAML- Metabolism and Therapeutic Resistance In Acute Myeloid Leukemia . Researchers from the Toulouse Cancer Research...
Jean-Emmanuel Sarry receives the Guy Lazorthes Prize of the Academy of Sciences 2022
Talents& Awards AWARD The Guy Lazorthes 2022 prize is awarded to Jean-Emmanuel SARRY. Inserm research director, head of the Metabolism and therapeutic resistance in acute myeloid leukaemia team at the Toulouse Cancer Research Centre (CRCT –...